Unknown

Dataset Information

0

Combination of lyophilized adipose-derived stem cell concentrated conditioned medium and polysaccharide hydrogel in the inhibition of hypertrophic scarring.


ABSTRACT:

Background

Mesenchymal stem cell-based acellular therapies have been widely exploited in managing hypertrophic scars. However, low maintenance dose and transitory therapeutic effects during topical medication remain a thorny issue. Herein, this study aimed to optimize the curative effect of adipose-derived stem cell conditioned medium (ADSC-CM) in the prevention of hypertrophic scarring.

Methods

In the present study, ADSC-CM was concentrated via the freeze-drying procedure. The efficacy of different dose groups (CM, CM5, CM10) was conducted on the proliferation, apoptosis, and ?-smooth muscle actin (?-SMA) expression of human keloid fibroblasts (HKFs) in vitro. Incorporation of adipose-derived stem cell concentrated conditioned medium (ADSCC-CM) into polysaccharide hydrogel was investigated in rabbit ear, in vivo. Haematoxylin-eosin (H&E) and Masson's trichrome staining were performed for the evaluation of scar hyperplasia.

Results

We noted that ADSCC-CM could downregulate the ?-SMA expression of HKFs in a dose-dependent manner. In the rabbit ear model, the scar hyperplasia in the medium-dose group (CM5) and high-dose group (CM10) was inhibited with reduced scar elevation index (SEI) under 4?months of observation. It is noteworthy that the union of CM5 and polysaccharide hydrogel (CM5+H) yielded the best preventive effect on scar hyperplasia. Briefly, melanin, height, vascularity, and pliability in the CM5+H group were better than those of the control group. Collagen was evenly distributed, and skin appendages could be regenerated.

Conclusions

Altogether, ADSCC-CM can downregulate the expression of ?-SMA due to its anti-fibrosis effect and promote the rearrangement of collagen fibres, which is integral to scar precaution. The in situ cross bonding of ADSCC-CM and polysaccharide hydrogel could remarkably enhance the therapeutic outcomes in inhibiting scar proliferation. Hence, the alliance of ADSCC-CM and hydrogel may become a potential alternative in hypertrophic scar prophylaxis.

SUBMITTER: Zhang C 

PROVIDER: S-EPMC7792059 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Combination of lyophilized adipose-derived stem cell concentrated conditioned medium and polysaccharide hydrogel in the inhibition of hypertrophic scarring.

Zhang Chaoyu C   Wang Ting T   Zhang Li L   Chen Penghong P   Tang Shijie S   Chen Aizhen A   Li Ming M   Peng Guohao G   Gao Hangqi H   Weng Haiyan H   Zhang Haoruo H   Li Shirong S   Chen Jinghua J   Chen Liangwan L   Chen Xiaosong X  

Stem cell research & therapy 20210107 1


<h4>Background</h4>Mesenchymal stem cell-based acellular therapies have been widely exploited in managing hypertrophic scars. However, low maintenance dose and transitory therapeutic effects during topical medication remain a thorny issue. Herein, this study aimed to optimize the curative effect of adipose-derived stem cell conditioned medium (ADSC-CM) in the prevention of hypertrophic scarring.<h4>Methods</h4>In the present study, ADSC-CM was concentrated via the freeze-drying procedure. The ef  ...[more]

Similar Datasets

| S-EPMC4897251 | biostudies-literature
| S-EPMC8770320 | biostudies-literature
| S-EPMC9034017 | biostudies-literature
| S-EPMC5275771 | biostudies-literature
| S-EPMC9470574 | biostudies-literature
| S-EPMC3982496 | biostudies-literature
| S-EPMC9100239 | biostudies-literature
2021-06-22 | GSE178562 | GEO
| S-EPMC6266848 | biostudies-other
| S-EPMC4878330 | biostudies-literature